CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 53  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0754
LYS 10.0122
GLU 20.0186
LEU 30.0168
ARG 40.0367
CYS 50.0212
GLN 60.0360
CYS 70.0352
ILE 80.0399
LYS 90.0245
THR 100.0134
TYR 110.0133
SER 120.0226
LYS 130.0216
PRO 140.0082
PHE 150.0069
HIS 160.0233
PRO 170.0184
LYS 180.0172
PHE 190.0180
ILE 200.0155
LYS 210.0252
GLU 220.0225
LEU 230.0125
ARG 240.0134
VAL 250.0155
ILE 260.0140
GLU 270.0069
SER 280.0213
GLY 290.0372
PRO 300.0168
HIS 310.0155
CYS 320.0131
ALA 330.0154
ASN 340.0086
THR 350.0153
GLU 360.0141
ILE 370.0142
ILE 380.0085
VAL 390.0095
LYS 400.0185
LEU 410.0146
SER 420.0179
ASP 430.0206
GLY 440.0170
ARG 450.0020
GLU 460.0121
LEU 470.0055
CYS 480.0086
LEU 490.0121
ASP 500.0159
PRO 510.0116
LYS 520.0343
GLU 530.0262
ASN 540.0226
TRP 550.0224
VAL 560.0204
GLN 570.0190
ARG 580.0224
VAL 590.0100
VAL 600.0058
GLU 610.0151
LYS 620.0165
PHE 630.0075
LEU 640.0079
LYS 650.0072
ARG 660.0104
ALA 670.0272
GLU 680.0754
ASN 690.0679

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.